Home > Insider Trading > Filing (0001181431-14-029399)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1392380	Gevo Inc.	GEVO	Industrial Organic Chemicals (2860)	870747704

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1511463	Brett Lund	Gevo, Inc., 345 Inverness Drive South Building C, Suite 310 Englewood CO 80112	Evp, Gc And Secretary	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2014-08-13	619	$0.48	109,518	No	4	S	Direct
Common Stock	Disposition	2014-08-15	480	$0.46	109,038	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct
No	4	S	Direct

Footnotes

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $.47 to $.50, inclusive. The reporting person undertakes to provide to Gevo, Inc., any security holder of Gevo, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (1) to this Form 4.
The shares sold represent shares of restricted stock granted to the reporting person that vested at the end of 2012. Such shares were sold, in part, to recoup certain tax obligations of the reporting person triggered by the vesting of such shares. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 16, 2013.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $.46 to $.47, inclusive. The reporting person undertakes to provide to Gevo, Inc., any security holder of Gevo, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (1) to this Form 4.